Track topics on Twitter Track topics that are important to you
Immunopheresis, which already secured breakthrough device designation from the US Food and Drug Administration (FDA), is a non-pharmaceutical solution to treat treating stage IV metastatic cancer. The company
The post Immunicom recruits first patient in TNBC trial of Immunopheresis appeared first on NS Medical Devices.
Original Article: Immunicom recruits first patient in TNBC trial of ImmunopheresisNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...